Biocon Board of Directors

Get the latest insights into the leadership at Biocon. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Kiran Mazumdar-ShawChairperson
Ravi Rasendra MazumdarNon Independent & Non Executive Director
Eric Vivek MazumdarNon Independent & Non Executive Director
Naina Lal KidwaiLead Independent Director
Bobby Kanubhai ParikhNon Executive Independent Director
Rekha Mehrotra MenonNon Executive Independent Director
Nicholas Robert HaggarNon Executive Independent Director
Atul DhawanNon Executive Independent Director
Rajesh Umakant ShanoyCompany Secretary and Compliance Officer

Biocon Share price

BIOCON

357.65

3.85 (-1.07%)
NSE
BSE
Last updated on 22 Apr, 2026 | 14:21 IST
Today's High

362.50

Today's Low

356.20

52 Week Low

308.45

52 Week High

424.95

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Biocon FAQs

The board at Biocon consists of experienced professionals, including Kiran Mazumdar-Shaw, Ravi Rasendra Mazumdar, and others, overseeing the company’s strategic and corporate governance.

Directors at Biocon are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Kiran Mazumdar-Shaw is the current chairman at Biocon.

Executive directors at Biocon are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Biocon adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Biocon, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost